Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial
Oscar Kristiansen(University of Oslo), John Munkhaugen(University of Oslo), Lars Gullestad(Apple (Israel)), Toril Dammen(Oslo University Hospital), Kari Peersen(Oslo University Hospital), Joep Perk(Linnaeus University), Nils Tore Vethe(Oslo University Hospital), Morten Lindberg(Sykehuset i Vestfold), Elena Prunés Jensen(Vestre Viken Hospital Trust), Einar Husebye(Drammen Hospital), Elise Sverre(University of Oslo), Erik Gjertsen(Drammen Hospital), Stein Bergan(Oslo University Hospital), Jan Erik Otterstad(Sykehuset i Vestfold), Morten Wang Fagerland(Oslo University Hospital)
Cited by 25
Related Papers
Rosuvastatin in Older Patients with Systolic Heart Failure
|New England Journal of Medicine|2007|1.5k
Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis
|European Journal of Preventive Cardiology|2017|402
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study
|European Heart Journal|2011|357
Prehypertension, Obesity, and Risk of Kidney Disease: 20-Year Follow-up of the HUNT I Study in Norway
|American Journal of Kidney Diseases|2009|156
Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis
|European Heart Journal - Cardiovascular Pharmacotherapy|2018|121